
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein Inc. has demonstrated strong financial performance, particularly in its Global Technology segment, which achieved a revenue of $173 million and experienced growth rates of 9.7% as reported and 9.0% on a local internal basis. Additionally, the dental equipment revenue surged by 10.6%, further showcasing robust demand within the dental sector. Overall, the growth in both medical products and dental business revenues, along with the anticipation of mid-single-digit growth in adjusted EBITDA for 2025 compared to FY/24, underscores a positive outlook for the company's financial trajectory.
Bears say
Henry Schein Inc. reported a gross margin for the quarter of 30.7%, which fell short of the expectation of 31.6%, reflecting challenges in its distribution and specialty products businesses. Additionally, the company anticipates lower remeasurement gains in 2026 compared to 2025, despite having fully incorporated this into its financial guidance, indicating potential future pressure on profitability. While adjusted EBITDA exceeded expectations at $291 million compared to the forecast of $284 million, the overall unfavorable mix in product offerings raises concerns about sustainable revenue growth and margin stability.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares